Tobias Tritschler
Overview
Explore the profile of Tobias Tritschler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
2011
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofstetter R, Stalder O, Tritschler T, Mean M, Rodondi N, Righini M, et al.
J Thromb Haemost
. 2025 Feb;
PMID: 39956430
Background: The impact of central localization of pulmonary embolism (PE) on clinical outcomes is uncertain. Objectives: To compare clinical presentation, risk factors, and outcomes between patients with central pulmonary embolism...
2.
Hofmann E, Stalder O, Mean M, Rodondi N, Tritschler T, Righini M, et al.
Thromb Haemost
. 2025 Jan;
PMID: 39870107
Background: Studies found an association between anemia and overall mortality and major bleeding (MB) in patients with acute venous thromboembolism (VTE), but whether anemia is causally related to death, bleeding,...
3.
Vale C, Godolphin P, Fisher D, Higgins J, McAleenan A, Spiga F, et al.
Ann Intern Med
. 2024 Dec;
178(1):59-69.
PMID: 39715559
Background: Reported results of clinical trials assessing higher-dose anticoagulation in patients hospitalized for COVID-19 have been inconsistent. Purpose: To estimate the association of higher- versus lower-dose anticoagulation with clinical outcomes....
4.
Stuby J, Stalder O, Limacher A, Righini M, Rodondi N, Tritschler T, et al.
Ann Hematol
. 2024 Sep;
103(11):4721-4729.
PMID: 39249495
An abnormal platelet count (PC) is common in acute venous thromboembolism (VTE) but its relationship with clinical outcomes remains ill-defined. We aimed to explore the association between baseline PC and...
5.
Khalife R, Burnett A, Tritschler T, Waldron B, Xu Y
BMJ
. 2024 Aug;
386:e079520.
PMID: 39214564
No abstract available.
6.
Magyar U, Stalder O, Baumgartner C, Mean M, Righini M, Schuetz P, et al.
J Thromb Haemost
. 2024 Jul;
22(2):516-525.
PMID: 38966659
Background: Health-related quality of life (QoL) impairment is common after pulmonary embolism (PE). Whether the severity of the initial PE has an impact on QoL is unknown. Objectives: To evaluate...
7.
Godoy L, Neal M, Goligher E, Cushman M, Houston B, Bradbury C, et al.
JACC Adv
. 2024 Jun;
3(3):100780.
PMID: 38938844
Background: Clinical trials suggest that therapeutic-dose heparin may prevent critical illness and vascular complications due to COVID-19, but knowledge gaps exist regarding the efficacy of therapeutic heparin including its comparative...
8.
Baumgartner C, Tritschler T, Aujesky D
Hamostaseologie
. 2023 Oct;
44(3):197-205.
PMID: 37871632
Subsegmental pulmonary embolism (SSPE) is increasingly diagnosed with the growing use and technological advancements of multidetector computed tomography pulmonary angiography. Its diagnosis is challenging, and some presumed SSPE may actually...
9.
Kocher B, Darbellay Farhoumand P, Pulver D, Kopp B, Choffat D, Tritschler T, et al.
Res Pract Thromb Haemost
. 2023 Sep;
7(6):102184.
PMID: 37745158
Background: Thromboprophylaxis (TPX) prescription is recommended in medical inpatients categorized as high risk of venous thromboembolism (VTE) by validated risk assessment models (RAMs), but how various RAMs differ in categorizing...
10.
Villiger R, Julliard P, Darbellay Farhoumand P, Choffat D, Tritschler T, Stalder O, et al.
Thromb Res
. 2023 Aug;
230:37-44.
PMID: 37634309
Introduction: Pharmacological thromboprophylaxis slightly increases bleeding risk. The only risk assessment model to predict bleeding in medical inpatients, the IMPROVE bleeding risk score, has never been validated using prospectively collected...